799-3862393-4/10001/1

Eli Lilly & Company — FEI 1819470

Refusal Details

Date
January 14, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCP74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
75